Table 3.

Clinical measures in PHIV patients (n [%] or median [IQR]).

Age at HIV diagnosis, y	0.50 (0.24–3.44)
CDC Stage C3	10 (40%)
Encephalopathy	3 (12%)
NADIR CD4, cells/mm3	249 (84–343)
NADIR CD4 (%)	11.9 (5–17)
CD4 count, cells/mm3	687 (497–830)
CD4 count (%)	32.7 (30–39)
CD4/CD8	0.99 (0.69–1.42)
Age at treatment onset, y	1.4 (0.3–4.2)
Age at onset on cART, y	2.3 (1.4–5.4)
Total time of treatment with cART	17.1 (14.8–18.5)
Number of cART regimens	7 (5–9)
Patients with uVL	21 (84%)
Time with uVL, y	10.8 (6.8–13.1)
VL in detectable patients, copies/mL	416 (185–530)
Type of CART
2 NRTIs + 1 NNRTI	3 (12%)
2 NRTIs + 1 PI	3 (12%)
2 NRTIs + 1 II	9 (36%)
1 PI + 1 II	3 (12%)
Other combinations	7 (28%)